LFMD LifeMD, Inc.
Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 948320 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.6%
TTM net income YoY95.6%
TTM EPS YoY91.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—
Margins
Gross margin84.1%
Operating margin-17.9%
Net margin-0.3%
FCF margin-7.5%
EBITDA margin-17.2%
Returns
ROE-125.9%
ROA-0.7%
ROIC (approx.)—
Asset turnover2.26x
Leverage & solvency
Liabilities / assets100.9%
Debt / equity—
Current ratio0.80x
Interest coverage92.33x
Cash quality & payout
Operating cash flow / net income23.16x
Accruals ratio15.5%
Payout ratio—
Capex / revenue0.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $194.06M | $154.82M | $152.55M | $119.03M | $92.88M |
| Cost of revenue | $27.71M | $21.44M | $18.90M | $18.67M | $18.00M |
| Gross profit | $166.34M | $133.38M | $133.65M | $100.37M | $74.88M |
| SG&A expense | $57.94M | $57.95M | $51.69M | $46.96M | $39.53M |
| Operating income | -$7.67M | -$20.40M | -$14.49M | -$43.45M | -$54.30M |
| Interest expense | $1.36M | $2.18M | $2.60M | $1.28M | $3.02M |
| Pretax income | -$10.19M | -$22.58M | -$17.41M | -$44.66M | -$61.32M |
| Income tax | $45,721 | $598,000 | $428,000 | $360,700 | $7,700 |
| Net income | $14.35M | -$21.41M | -$20.60M | -$45.54M | -$60.90M |
| EBITDA | -$6.80M | -$19.94M | -$14.29M | -$43.29M | -$54.29M |
| EPS (basic) | 0.25 | -0.60 | — | — | — |
| EPS (diluted) | 0.25 | -0.60 | — | — | — |
| Weighted avg. shares (diluted) | 45.13M | 41.20M | 33.91M | 30.98M | 27.01M |
| Balance sheet | |||||
| Cash & equivalents | $36.79M | $32.65M | $33.15M | $3.96M | $41.33M |
| Receivables | $2.49M | $10.46M | $6.27M | $2.83M | $980,055 |
| Inventory | $2.77M | $2.80M | $2.76M | $3.70M | $1.62M |
| Current assets | $45.01M | $52.37M | $42.60M | $11.31M | $44.92M |
| PP&E, net | $2.44M | $1.44M | $476,303 | $476,441 | $233,805 |
| Goodwill | — | — | — | $8.00M | $0 |
| Intangibles | $262,334 | $53,336 | $3.01M | $3.83M | $19,761 |
| Total assets | $63.59M | $76.10M | $58.48M | $25.67M | $49.92M |
| Current liabilities | $39.58M | $67.40M | $34.78M | $31.37M | $22.83M |
| Total liabilities | $45.26M | $83.65M | $52.91M | $32.97M | $24.10M |
| Shareholders' equity | $18.33M | -$9.08M | $3.51M | -$11.40M | $22.74M |
| Shares outstanding | 46.66M | 42.19M | 38.26M | 31.45M | 30.60M |
| Cash flow statement | |||||
| Operating cash flow | $8.28M | $17.51M | $8.82M | -$22.94M | -$33.09M |
| Capital expenditure | $1.87M | $1.46M | $203,814 | $366,633 | $247,365 |
| Free cash flow | $6.41M | $16.05M | $8.62M | -$23.30M | -$33.33M |
| Investing cash flow | $6.91M | -$11.54M | -$8.73M | -$13.91M | -$3.40M |
| Financing cash flow | -$13.41M | -$4.12M | $29.10M | -$528,200 | $68.64M |
| Depreciation & amortization | $865,524 | $465,830 | $203,952 | $161,885 | $13,560 |
| Stock-based compensation | $10.50M | $12.23M | $12.49M | $13.73M | $12.07M |
| Dividends paid | $3.11M | $3.11M | $3.11M | $3.11M | $871,476 |
| Share buybacks | $270,000 | — | — | — | — |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.